Chemed
330 hedge funds and large institutions have $4.69B invested in Chemed in 2018 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 77 increasing their positions, 131 reducing their positions, and 22 closing their positions.
200% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 22
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
15% more funds holding
Funds holding: 288 → 330 (+42)
12% more capital invested
Capital invested by funds: $4.17B → $4.69B (+$521M)
3% less call options, than puts
Call options by funds: $10.4M | Put options by funds: $10.7M
3.13% less ownership
Funds ownership: 94.61% → 91.49% (-3.1%)
41% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 131
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$56.3M |
| 2 |
Millennium Management
New York
|
+$39.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$35.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.9M |
| 5 |
VRS
Virginia Retirement Systems
Richmond,
Virginia
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$136M |
| 2 |
Neuberger Berman Group
New York
|
-$59.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45.9M |
| 5 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
-$45.7M |
CHE Hedge Fund Activity: Q2 2018 in Review
330 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2018, worth a combined $4.69B — up 12% from $4.17B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new CHE positions and 22 closed out — a net gain of 44 holders — while 77 added to existing stakes and 131 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $56.3M. The largest seller was BlackRock, cutting an estimated $136M.
- 330 institutional investors held Chemed (CHE) as of Q2 2018, up from 288 in Q1 2018.
- Funds reported $4.69B of Chemed stock for Q2 2018, up 12% quarter-over-quarter.
- 66 funds opened new Chemed positions in Q2 2018 and 22 closed out, a net change of +44 holders.
- The largest Chemed buyer in Q2 2018 was Goldman Sachs, an estimated $56.3M added.
- The largest Chemed seller in Q2 2018 was BlackRock, an estimated $136M sold.
Based on aggregated 13F filings for Q2 2018.